Moonlake Immunotherapeutics Stock Market Value
| MLTX Stock | USD 41.67 0.77 1.81% |
| Symbol | MoonLake |
MoonLake Immunotherapeuti Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MoonLake Immunotherapeuti. If investors know MoonLake will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MoonLake Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.12) | Return On Equity (0.15) |
The market value of MoonLake Immunotherapeuti is measured differently than its book value, which is the value of MoonLake that is recorded on the company's balance sheet. Investors also form their own opinion of MoonLake Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is MoonLake Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MoonLake Immunotherapeuti's market value can be influenced by many factors that don't directly affect MoonLake Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MoonLake Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if MoonLake Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MoonLake Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MoonLake Immunotherapeuti 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MoonLake Immunotherapeuti's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MoonLake Immunotherapeuti.
| 03/12/2024 |
| 06/10/2024 |
If you would invest 0.00 in MoonLake Immunotherapeuti on March 12, 2024 and sell it all today you would earn a total of 0.00 from holding MoonLake Immunotherapeutics or generate 0.0% return on investment in MoonLake Immunotherapeuti over 90 days. MoonLake Immunotherapeuti is related to or competes with Virios Therapeutics, Acumen Pharmaceuticals, Eton Pharmaceuticals, Nuvation Bio, and Larimar Therapeutics. MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies More
MoonLake Immunotherapeuti Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MoonLake Immunotherapeuti's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MoonLake Immunotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 11.74 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 5.44 |
MoonLake Immunotherapeuti Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MoonLake Immunotherapeuti's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MoonLake Immunotherapeuti's standard deviation. In reality, there are many statistical measures that can use MoonLake Immunotherapeuti historical prices to predict the future MoonLake Immunotherapeuti's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | (0.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MoonLake Immunotherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MoonLake Immunotherapeuti Backtested Returns
MoonLake Immunotherapeuti has Sharpe Ratio of -0.0469, which conveys that the firm had a -0.0469% return per unit of risk over the last 3 months. MoonLake Immunotherapeuti exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MoonLake Immunotherapeuti's Mean Deviation of 2.02, risk adjusted performance of (0.01), and Standard Deviation of 2.63 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.86, which conveys possible diversification benefits within a given portfolio. MoonLake Immunotherapeuti returns are very sensitive to returns on the market. As the market goes up or down, MoonLake Immunotherapeuti is expected to follow. At this point, MoonLake Immunotherapeuti has a negative expected return of -0.12%. Please make sure to verify MoonLake Immunotherapeuti's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if MoonLake Immunotherapeuti performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
MoonLake Immunotherapeutics has poor predictability. Overlapping area represents the amount of predictability between MoonLake Immunotherapeuti time series from 12th of March 2024 to 26th of April 2024 and 26th of April 2024 to 10th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MoonLake Immunotherapeuti price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current MoonLake Immunotherapeuti price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 2.03 |
MoonLake Immunotherapeuti lagged returns against current returns
Autocorrelation, which is MoonLake Immunotherapeuti stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MoonLake Immunotherapeuti's stock expected returns. We can calculate the autocorrelation of MoonLake Immunotherapeuti returns to help us make a trade decision. For example, suppose you find that MoonLake Immunotherapeuti has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MoonLake Immunotherapeuti regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MoonLake Immunotherapeuti stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MoonLake Immunotherapeuti stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MoonLake Immunotherapeuti stock over time.
Current vs Lagged Prices |
| Timeline |
MoonLake Immunotherapeuti Lagged Returns
When evaluating MoonLake Immunotherapeuti's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MoonLake Immunotherapeuti stock have on its future price. MoonLake Immunotherapeuti autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MoonLake Immunotherapeuti autocorrelation shows the relationship between MoonLake Immunotherapeuti stock current value and its past values and can show if there is a momentum factor associated with investing in MoonLake Immunotherapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| SGC | Superior Uniform Group | |
| VLN | Valens | |
| GNFT | Genfit |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.